Almac Group Ltd - Company Profile
Powered by 
All the sales intelligence you need on Almac Group Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Almac Group Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Almac Group Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Almac Group Ltd (Almac) is a contract development and manufacturing organization. The company provides integrated services to pharmaceutical and biotechnology companies. The company offers its services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to the commercialization of products. Its services portfolio include diagnostics and biomarker development, clinical technologies, active pharmaceutical ingredient (API) services and chemical development, pharmaceutical development, analytical services, clinical services and commercial services. The company operates through its subsidiaries in California, North Carolina, and Pennsylvania in the US, and Singapore. Almac is headquartered in Craigavon, Northern Ireland, the UK.
Almac Group Ltd premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Biomarker Discovery and Development: | Cancer DSA |
| Companion Diagnostic Development | Xcel |
| Biomarker Clinical Trial Management | Rapidd |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In March, Almac Sciences announced the launch of cGMP compliant flow high pressure hydrogenation. |
| 2025 | Corporate Changes/Expansions | In September, the company completed expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK. |
| 2025 | Corporate Changes/Expansions | In August, the company announced the official opening of new GMP-qualified analytical stability chambers and office space at its US Headquarter campus in Souderton, Pennsylvania. |
Competitor Comparison
| Key Parameters | Almac Group Ltd | IQVIA Holdings Inc | Incyte Corp | Codexis Inc | Cobra Biologics Ltd |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | United States of America | United States of America | United States of America | United Kingdom |
| City | Craigavon | Durham | Wilmington | Redwood City | Keele |
| State/Province | Northern Ireland | North Carolina | Delaware | California | Staffordshire |
| No. of Employees | 7,800 | 93,000 | 2,844 | 146 | 134 |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Alan David Armstrong | Chief Executive Officer; Chairman | Executive Board | 2002 | 68 |
| Graeme Thomas McBurney | Chief Operating Officer; Director | Executive Board | 2022 | 57 |
| Celine Bradley | Deputy Managing Director; Vice President - Operations - Almac Clinical Services | Senior Management | 2013 | - |
| John McQuaid | President - Almac Pharma Services; Managing Director - Almac Pharma Services | Senior Management | 2022 | - |
| Stephen Barr, Ph.D. | Managing Director - Almac Sciences & Almac Discovery; President - Almac Sciences & Almac Discovery | Senior Management | 2001 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer